



























quinuclidine	 and	 its	 C‐nucleosides.	 The	 reaction	 of	 1	 with	 formalin	 and	 secondary	 amines
namely;	morpholine,	piperidine,	and	piperazine	afforded	the	corresponding	Mannich	bases	2‐
4	 in	 acid	 medium.	 Quinuclidino[3,2‐b]pyran	 5	 has	 been	 synthesized	 via	 a	 selective
cyclocondensation	 reaction	 between	 Mannich	 base	 of	 quinuclidinone	 hydrochloride	 2	 and
malononitrile.	The	transformation	of	1	with	formalin	and	methylamine	in	molar	ratio	(1:20:2)
afforded	the	spiro	compound	7.	Ring	expansion	of	2	under	Schmidt	reaction	conditions	gave
the	 1,3‐diazabicyclo[3.2.2]nonanone	 derivative	6.	 Eventually,	 the	 synthesis	 of	C‐nucleosides
10,	12‐14	were	 achieved	by	using	 aldohexoses	 and	 aldopentose	 catalyzed	 by	 zinc	 chloride,











Quinuclidine	 is	 a	 part	 of	 the	 structure	 of	 a	 number	 of	
natural	 physiologically	 active	 compounds	 and	 synthetic	 drugs	
[1‐3].	 Some	 functionalized	 synthetic	 quinuclidines	 have	 also	
been	identified	as	specific	muscarinic	agonists	with	potential	in	
Alzheimer’s	dementia	therapy	[4,5].	Also,	used	in	the	synthesis	
of	 higher	 thermodynamic	 stability	 of	 quinuclidine	 complexes,	
as	1‐quinuclidine‐1‐boraadamantane	[6].	Moreover	a	variety	of	
quaternary	 quinuclidinium	 salts	 synthesized	 via	 the	
Menschutkin	 reaction	 as	 N‐ethoxycarbonylmethyl‐quinucli‐
dinium	 chloride	 dihydrate,	 QNBE‐Cl‐2H2O	 and	 quinuclidine	
betaine	 hydrate	 (N‐carboxymethyl‐quinuclidinium	 inner	 salt,	
QNB‐H2O)	[7,8].	As	much	as	the	incorporation	of	Mannich	bases	
into	 heterocyclic	 moieties	 is	 known	 to	 improve	 their	
pharmacological	 properties	 [9,10],	 as	 well	 as	 synthetic	
potentialities	 [11‐15],	 it	 seemed	 interesting	 to	 prepare	 the	
Mannich	 bases	 of	 quinuclidin‐3‐one	 (1)	 to	 investigate	 their	
synthetic	 potentialities.	 The	 Menschutkin	 reaction	 results	 in	
formation	 of	 a	 variety	 of	 quaternary	 quinuclidinium	 salts.	
Recently,	 the	 structures	 of	 N‐ethoxycarbonylmethyl‐
quinuclidinium	 chloride	 dihydrate,	 QNBE‐Cl‐2H2O,	 [7,8]	 and	
quinuclidine	 betaine	 hydrate	 (N‐carboxymethyl‐quinucli‐
dinium	inner	salt,	QNB‐H2O)	[7,8]	were	reported.	
We	 reported	 herein	 the	 synthesis	 of	 novel	 heterocycle‐
annulated	 quinuclidine(1‐azabicyclo[2.2.2]octane)	 and	 spiro	









melting	 point	 apparatus.	 Elemental	 analyses	 were	 performed	
on	 an	 ECS	 4010	 Elemental	 combustion	 system	 at	 the	
Microanalytical	 Unit,	 Faculty	 of	 Science,	 Cairo	 University.	 The	
FTIR	spectra	were	measured	using	KBr	disc	on	a	Mattson	5000	
FTIR	spectrometer.	The	1H	NMR	data	were	obtained	in	CDCl3	or	
DMSO‐d6	 on	 Varian	 XL	 200	 MHz	 instrument	 using	 TMS	 as	
internal	 standard.	 Chemical	 shifts	 were	 reported	 in	 ppm	 (δ)	
downfield	 from	 internal	 TMS	 and	 coupling	 constants	 were	
















in	ethanol	 (15	cm3)	 for	8	h	over	water	bath.	After	adding	 few	
drops	 of	 hydrochloric	 or	 acetic	 acids,	 the	 precipitate	 was	




ppm):	1.8‐2.4	 (m,	4H,	 (CH2)2C),	 2.66	 (m,	1H,	bridgehead),	3.2‐
4.2	 (complex	 pattern.,	 14H,	 (CH2)5N	 and	 (OCH2)2),	 5.6	 (t,	 1H,	
NCHCO).	 IR	 (cm‐1):	 1751	 (CO).	 MS	 (m/z,	 (%)):	 224	 (M+‐HCl,	
4.70%),	138	(11.0),	137	(21.1),	125	(9.8),	124	(9.4),	123	(15.5),	
108	 (25.7),	 101	 (7.4),	 100	 (32.6),	 56	 (28.8),	 55	 (100).	 Anal.	














White	crystals.	Yield:	25%.	M.p.:	250	 °C.	 IR	 (cm‐1):	1746	 (CO).	
MS	(m/z,	(%)):	222	(M+‐CH3COOH,	0.1%),	221	(0.1),	137	(19.8),	






Compound	 1	 (0.8	 g,	 5	 mmol)	 was	 added	 to	 a	 mixture	 of	
formalin	(0.2	g,	6	mmol)	and	piperazine	(0.46	g,	2.5	mmol)	 in	
ethanol	 (15	 cm3).	 The	 reaction	 mixture	 was	 refluxed	 for	 2	 h	
over	 water	 bath.	 After	 addition	 of	 few	 drops	 of	 concentrated	
hydrochloric	 acid,	 the	 precipitate	 was	 formed,	 filtered	 off,	
washed	 with	 ethanol,	 dried	 and	 crystallized	 from	 ethanol	 to	
give	the	bis(quinuclidin‐3‐one)	4	as	white	crystals	(Scheme	1).	
Yield:	 51.7%.	 M.p.:	 274	 °C.	 IR	 (cm‐1):	 1745,	 1750	 (2CO).	 MS	
(m/z,	 (%)):	 363	 (M+3,	 3.8%),	 303	 (3.9),	 236	 (2.7),	 235	 (2.7),	
224	(2.7),	138	(3.5),	125	(3.1),	124	(5.0),	123	(4.5),	112	(3.9),	
110	 (8.1),	 84	 (1.2),	 82	 (10.6),	 69	 (100).	 Anal.	 calcd.	 for	







(10	 cm3)	 and	 malononitrile	 (0.05	 g,	 0.7	 mmol)	 heated	 for	
deamination	[detected	by	red	litmus	paper	change	to	blue]	then	
evaporated	 ethanol	under	 reduced	pressure	 then	 the	 reaction	
mixture	 was	 refluxed	 in	 dry	 toluene	 for	 3	 h.	 The	 reaction	
mixture	 was	 left	 to	 stand	 overnight;	 after	 the	 solvent	 was	
evaporated	 an	 oily	 product	 was	 obtained	 which	 crystallized	
from	 ethanol	 to	 give	 5	 as	 brown	 crystals	 (Scheme	 1).	 Yield:	
42.2%.	M.p.:	205	°C.	1H	NMR	(CDCl3,	,	ppm):	1.90‐2.19	(m,	4H,	
(CH2)2C),	 2.52	 (s,	 2H,	 NH2),	 3.24‐3.31	 (m,	 5H,	 bridgehead	














h,	 then	 further	 at	 25°C	 for	 4	 h.	 It	was	 diluted	with	 ice	water	
basified	with	 ammonia	 (40%),	 then	 extracted	with	 ether	 (3	 x	
15	cm3);	the	ether	solution	was	dried	on	sodium	sulphate	and	
evaporated	 under	 vacuum	 to	 give	 a	 solid	 product	 which	was	
crystallized	 from	 ether/petroleum	 ether	 40‐60°C	 to	 give	6	 as	
white	 crystals	 (Scheme	1).	Yield:	25%.	M.p.:	265	°C.	 IR	 (cm‐1):	















2.5	 (m,	 1H,	 bridgehead),	 3.36‐3.39	 (complex	 pattern,	 8H,	
(CH2)4N),	3.99	(s,	2H,	N‐CH2‐N).	IR	(cm‐1):	1751	(CO).	MS	(m/z,	
(%)):	221	 (M+‐2,	0.1%),	207	 (0.1),	 125	 (18.0),	 97	 (100).	Anal.	
























42%.	M.p.:	180	 °C.	 IR	 (cm‐1):	1751	 (CO),	3369	 (OH).	MS	 (m/z,	
(%)):	374	(M+,	7.3%),	158	(7.4),	125	(18.2),	99	(0.1),	98	(11.2),	
























General	 procedure:	 A	 mixture	 of	 1	 (0.59	 g,	 3	 mmol)	 and	
aldohexsoses	or	aldopentose	(3	mmol)	 in	ethanol	(5	cm3)	and	
bidistilled	water	 (0.5	 cm3)	was	heated	at	60	 °C	 for	20	min	on	
water	 bath.	 A	 catalytic	 amount	 of	 ZnCl2	 was	 added	 and	 the	
reaction	 mixture	 was	 heated	 till	 complete	 dissolution	 ZnCl2.	
The	 reaction	 mixture	 was	 filtered	 off	 and	 left	 to	 cool.	 The	
formed	precipitate	was	after	cooling	was	filtered	off,	dried	and	











125	 (28.1),	 103	 (9.4),	 97	 (100),	 96	 (49.6),	 73	 (5.1),	 60	 (6.5).	






125	 (23.8),	103	 (0.9),	 97	 (100),	96	 (57.8),	73	 (13.1),	60	 (3.8).	










194	 (2.99),	283	 (2.50).	MS	 (m/z,	 (%)):	286	 (M+‐H,	0.5%),	163	




(14):	White	 crystals.	Yield:	55%.	M.p.:	138	 °C.	 IR	 (cm‐1):	1744	
(C=O),	 2982	 (C‐H	 stretching),	 3437	 (OH).	 UV	 ((H2O,	 λmax,	 (log	
)):	 195	 (2.76),	252	 (1.80),	 257	 (184),	262	 (1.78),	 280	 (1.55).	
MS	(m/z,	(%)):	258	(M++1,	38.5%),	257	(M+,	35.4),	256	(M+‐H,	
31.3),	240	(33.3),	229	(37.5),	133	(35.4),	126	(33.3),	104	(39.6),	







Compound	 10	 (0.72	 g,	 2.5	 mmol)	 was	 refluxed	 in	 acetic	
anhydride/glacial	acetic	acid	(15	cm3,	1:1)	mixture	for	2	h,	and	
left	 to	 cool	 whereby	 a	 white	 precipitate	 was	 formed.	 The	
product	was	filtered	off,	dried	and	crystallized	from	ethanol	to	
give	0.91	g	of	11	as	white	crystals	(Scheme	3).	Yield:	80%.	M.p.:	
190	 °C.	 IR	 (cm‐1):	 1710	 (CO,	 acetate),	 1740	 (CO),	 2970	 (C‐H,	
stretching).	MS	 (m/z,	 (%)):	 454	 (M+‐H,	 0.5%),	 240	 (0.6),	 171	
(0.6),	170	(0.8),	167	(0.9),	161	(0.7),	137	(1.1),	124	(0.7),	104	








A	 mixture	 of	 1	 (0.8	 g,	 5	 mmol)	 and	 D‐glucose	 (0.9	 g,	 5	
mmol)	in	sodium	carbonate	solution	(15	cm3,	4%)	was	heated	
at	 90	 oC	 for	 6	 h.	 The	 reaction	 mixture	 was	 cooled,	 and	 then	
acidified	with	dilute	acetic	acid.	The	obtained	solid	product	was	
filtered	 off,	 dried	 and	 crystallized	 from	 ethanol	 to	 give	15	 as	
white	crystals	(Scheme	3).	Yield:	62%.	M.p.:	>290	°C.	IR	(cm‐1):	
1602	(C=C),	2961	(C‐H,	stretching),	3395	(OH).	MS	(m/z,	(%)):	























The	 target	 compounds	 were	 synthesized	 as	 outlined	 in	
Schemes	 1‐6.	 In	 light	 of	 the	 aforementioned	 importance	 of	
ketonic	 Mannich	 bases	 as	 precursors	 for	 the	 synthesis	 of	
heterocycle‐annulated	 quinuclidine(1‐azabicyclo[2.2.2]octane)	
derivatives,	 therefore	 compound	1	 was	 subjected	 to	Mannich	
reaction	with	morpholine,	 piperidine	 and	 formalin	 in	 a	molar	
ratio	 (1:1:1.2)	 to	 afford	 salts	 of	 the	 Mannich	 bases	 2	 and	 3,	
respectively,	 which	 were	 reported	 as	 free	 bases	 [16].	 In	
addition,	the	interesting	pharmacological	activity	of	piperazine	
derivatives	 [17‐19],	 prompted	 us	 to	 prepare	 1,4‐bis(4‐yl‐
methyl‐1‐aza‐bicyclo[2.2.2]octane‐3‐one)piperazine	 (4)	
through	 the	 reaction	 of	 1	 with	 piperazine	 and	 formalin	 in	 a	
molar	ratio	of	(2:1:2)	(Scheme	1).	
Formulation	 of	 structures	 2‐4	 was	 based	 on	 elemental	





peak	at	m/z	100	which	 is	due	 to	 [CH2N+(CH2CH2)2O]	fragment	
and	 the	 base	 peak	 at	m/z	 55.	 This	 peak	 is	 probably	 due	 to	
fragmentation	of	the	morpholinomethylene	(Scheme	4).	
Ketonic	Mannich	 bases	 are	 of	 considerable	 importance	 as	
versatile	 precursors	 in	 the	 synthesis	 of	 heterocycles	 [20‐22].	
With	a	view	to	effect	a	“one‐pot”	C‐alkylation	and	cyclization	of	
the	 Mannich	 base	 2,	 the	 reaction	 of	 4‐((3‐oxoquinuclidin‐2‐
yl)methyl)morpholin‐4‐ium	chloride	 (2)	with	malononitrile	 in	
refluxing	 toluene	 was	 implemented	 to	 give	 2‐amino‐3‐
cyanoquinuclidino[3,2‐b]pyran(5‐amino‐6‐oxa‐1‐aza‐tricyclo	
[6.2.2.02,7]dodeca‐2(7),4‐diene‐carbonitrile)	 (5).	 Its	 structure	
was	supported	by	elemental	and	spectral	data.	Presumable	the	
formation	of	5	proceeds	via	deamination	of	the	Mannich	base	2	
to	 form	 2‐methylenequinuclidine‐3‐one	 which	 undergoes	
thermal	 Micheal	 addition	 of	 the	 acidic	 methylene	 group	 of	
malononitrile	 followed	 by	 nucleophilic	 addition	 of	 enolic	 OH	
group	to	the	carbon	atom	of	cyano	group	(Scheme	5).	
When	 compound	 2	 was	 treated	 with	 sodium	 azide	 in	
presence	of	sulfuric	acid	under	Schmidt	condition	gave	the	1,3‐





















1,3‐diazepine	 with	 formaldehyde	 gave	 the	 N‐bis	 compound.	
Formulation	of	structure	6	was	proved	in	light	of	its	elemental	
analysis,	 IR	 and	mass	 spectral	 data.	 Its	mass	 spectrum	 added	
further	 support	 to	 the	 assigned	 structure,	 as	 it	 revealed	 the	
molecular	ion	peak	at	m/z	239	(M+,	75%).	
The	 quinuclidine	 nucleus	 is	 the	 core	 component	 of	 the	
cinchona	alkaloids,	a	family	of	natural	products,	which	not	only	
exhibited	antimalarial	activity	but	also	found	to	be	widespread	
use	 in	 numerous	 asymmetric	 transformations	 [23‐27],	 and	
pyrimidine	 derivatives	 from	 bridged	 alicyclic	 ketones	 act	 as	
dihydrofolate	 reductase	 inhibitor	 [28].	 Consequently,	 1	 was	
transformed	with	 a	 mixture	 of	 formalin	 and	 methylamine	 in	
molar	 ratio	 (1:20:2)	 under	 Mannich	 conditions	 to	 afford	 1,4‐
ethano‐8,10‐dimethyl‐1,8,10‐triaza‐spiro[5.5]undecan‐5‐one	
(7)	 as	 spiro	 compound.	 It	 was	 probably	 formed	 through	 the	
formation	 of	 the	 intermediate	 2,2‐bis‐methylol‐3‐
quinuclidinone	followed	by	amination	with	methylamine,	 then	
by	subsequent	cyclization	with	excess	of	 formalin	(Scheme	6).	
This	 mechanism	 was	 supported	 by	 the	 work	 of	 Nielsen	 [29]	




1	 with	 glucose	 and	 morpholine	 under	 Mannich	 reaction	
conditions	(Scheme	1).	
A	 series	 of	 spirohydantoins	 [30,31],	 were	 reported	 as	
compounds	 have	 several	 pharmacological	 activities	 [32,33].	
Therefore,	we	synthesized	spirothiohydantoin	9	for	the	sake	of	
improving	 pharmacological	 potency	 of	 quinuclidine.	 Hence,	
quinuclidinone	1	 was	 transformed	 by	 potassium	 cyanide	 and	
thiourea	 in	 ethanol	 into	 9.	 The	 reaction	 pathway	 was	
proceeded	 via	 cyanohydrin	 intermediate	 [34],	 followed	 by	
condensation	with	thiourea	to	furnish	compound	9	(Scheme	2).	
The	 structure	 of	 9	 was	 proved	 by	 its	 IR,	 1H	 NMR	 and	 mass	
spectra.	 The	 IR	 spectrum	 of	 9	 revealed	 a	 broad	 band	 in	 the	
2500‐2800	 cm‐1	 region,	 similar	 to	 the	 absorption	 formed	 in	
other	 azabicyclospirohydantoins	 [35],	 this	 absorption	 is	
explained	by	the	existence	of	an	intermolecular	hydrogen	bond	
which	 is	 formed	between	 the	weak	 acid	N‐3`H	 group	 and	 the	
basic	 1‐aza‐bicylco[2.2.2]octane	 nitrogen	 atom.	 The	 N‐1`H	
stretching	vibration	originates	a	band	in	the	3311	cm‐1	region.	
The	 carbonyl	 region	 shows	 a	 very	 strong	 band	 at	 1736	 cm‐1;	
and	also	strong	band	at	1087	cm‐1	characteristic	 for	C=S.	This	
interpretation	 is	 supported	 by	 studies	 carried	 out	 on	 other	
azabicyclo‐spirohydantoins	[36].	
The	discovery	of	C‐nucleosides	and	 their	antibacterial	and	
antitumor	 properties	 [37‐40],	 and	 also	 electrophilic	 C‐
glycosylation	 of	 electron	 rich	 aromatic	 and	 the	 heterocyclic	
systems	 is	 widely	 found	 in	 nature	 [37‐40].	 Therefore,	 our	
attention	was	directed	 to	 the	development	of	 synthetic	 routes	
to	this	class	of	compounds.	Surprisingly,	a	facile	synthesis	of	C‐
nucleoside	 derivatives	 of	 quinuclidin‐3‐one	 (1)	 was	 achieved	
by	 the	 reaction	 with	 different	 aldoses.	 In	 this	 method,	 the	
reaction	of	1	with	D‐glucose	was	conducted	in	absolute	ethanol	
at	60	oC	for	20	min.	in	the	presence	of	catalytic	amount	of	zinc	




The	 acetylation	 of	 10	 was	 implemented	 using	 acetic	
anhydride	 and	 acetic	 acid	 mixture	 with	 subsequent	
dehydration	 to	 give	 the	 acetylated	C‐nucleoside	11.	 The	mass	
spectrum	of	11	showed	the	molecular	ion	peak	at	m/z	454	(M+‐
H,	0.51%).	
Formulation	 of	 structure	 10	 was	 based	 on	 elemental	
analysis,	 IR,	UV,	1H	NMR	and	mass	spectral	data.	The	coupling	
constant	 of	 the	 anomeric	 proton	was	 3.4	 Hz	 indicated	 the	α‐
configuration	of	the	glucose	moiety.	Its	mass	spectrum	showed	
the	molecular	ion	peak	at	m/z	287	(M+,	6.5%).	
On	 the	 other	 hand,	 condensation	 of	 1	 with	 D‐glucose	 in	
sodium	 carbonate	 as	 a	 basic	 catalyst	 instead	 of	 zinc	 chloride	
afforded	 the	 bis‐quinuclidine	 sugar	 15.	 Its	 structure	 was	
confirmed	by	elemental	 analysis	 and	mass	 spectrum.	 Its	mass	
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